Related Experiment Video
Updated: Jun 24, 2026
A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
Published on: October 14, 2016
Acute Myeloid Leukemia with MECOM Rearrangement Presenting with Striking Hemophagocytosis
1Department of Clinical Laboratory, The First Hospital of Qinhuangdao, No. 258 Wenhua Road, Qinhuangdao, 066000 China.
Insights
This report details a rare case of acute myeloid leukemia (AML) with MECOM rearrangement and significant hemophagocytosis. The findings challenge current diagnostic criteria, emphasizing the need for updated classification systems in hematologic malignancies.
Area of Science:
- Hematology
- Oncology
- Genetics
Background:
- Acute myeloid leukemia (AML) is a heterogeneous clonal hematopoietic stem cell disorder.
- MECOM rearrangements are rare genetic abnormalities observed in AML.
- Hemophagocytosis, a syndrome of excessive immune activation, can complicate AML presentation.
Purpose of the Study:
- To report the first case of AML with MECOM rearrangement presenting with prominent hemophagocytosis.
- To highlight the diagnostic challenges posed by differing AML classification systems.
- To discuss the clinical implications of this rare AML subtype.
Main Methods:
- Case report of a 65-year-old female patient.
- Review of diagnostic criteria including WHO-HAEM5.
- Genetic analysis for MECOM rearrangement.
- Clinical and pathological evaluation of hemophagocytosis.
Main Results:
- The patient presented with AML and a MECOM rearrangement.
- Prominent hemophagocytosis was a key clinical feature.
- The case met WHO-HAEM5 criteria despite less than 20% blasts.
- This presentation highlights discrepancies between classification systems.
Conclusions:
- AML with MECOM rearrangement can present with significant hemophagocytosis.
- Diagnostic criteria for AML require careful consideration in cases with atypical features.
- Further research is needed to refine AML classification and diagnostic approaches for rare subtypes.
Abstract:
This first report described a 65-year-old female with AML with MECOM rearrangement, presenting with prominent hemophagocytosis. The case met WHO-HAEM5 diagnostic criteria despite < 20% blasts, highlighting both a novel clinical feature and the diagnostic challenge posed by differing classification systems.
